Product Images Doxepin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Doxepin Hydrochloride NDC 23155-797 by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

avet-spl-logo - avet spl logo

avet-spl-logo - avet spl logo

doxepin-spl-100mg100scount - doxepin spl 100mg100scount

doxepin-spl-100mg100scount - doxepin spl 100mg100scount

doxepin-spl-10mg100scount - doxepin spl 10mg100scount

doxepin-spl-10mg100scount - doxepin spl 10mg100scount

doxepin-spl-25mg100scount - doxepin spl 25mg100scount

doxepin-spl-25mg100scount - doxepin spl 25mg100scount

This text appears to be a prescription drug label for Doxepil Hydrochloride capsules, manufactured by Avet Pharma. The label includes information such as the dosage and quantity, as well as an NDC number for identification.*

doxepin-spl-50mg100scount - doxepin spl 50mg100scount

doxepin-spl-50mg100scount - doxepin spl 50mg100scount

This is a product description. Avet Pharma® produces a capsule medication with the active ingredient Hydrochloride Doxepin. The product comes in a pack of 100 capsules and the NDC code is 23155-796-01. Pharmacists are advised to provide a medication guide to patients for proper use. The location and other details of the manufacturer cannot be identified from the given text.*

doxepin-spl-75mg100scount - doxepin spl 75mg100scount

doxepin-spl-75mg100scount - doxepin spl 75mg100scount

This text contains information about medication capsules labeled as Doxepin with a strength of 75mg and 100 capsules in the bottle. It also includes the NDC number 23155-797-01. The text may be a label or package insert for this medication.*

doxepin-spl-mgtable - doxepin spl mgtable

doxepin-spl-mgtable - doxepin spl mgtable

This text describes warning signs of suicidal behavior, changes in mood and behavior such as increased irritability or anxiety, and physical symptoms such as eye pain or changes in vision. It suggests that some individuals may be at risk for these problems and may benefit from an eye examination to receive preventative treatment.*

doxepin-spl-structure - doxepin spl structure

doxepin-spl-structure - doxepin spl structure

doxepin-spl-table-1 - doxepin spl table1

doxepin-spl-table-1 - doxepin spl table1

The text describes a table indicating the number of cases of suicidality for patients in different age ranges and drug treatments. The age range is divided into two groups: under 18 and 18 to 24. The table is divided into three columns indicating increases or decreases in the number of cases of suicidality compared to placebo. The first group had 14 additional cases, and the second group had five additional cases when compared to the placebo treatment. The third column indicates that there was a decrease of one or six cases of suicidality for the respective drug treatments.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.